DC
MNTA

Deere & Company’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Deere & Company’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-36,181
Closed -$423K – 864
2016
Q3 		$423K Hold
36,181
– – 0.02% 731
2016
Q2 		$391K Buy
+36,181
New +$373K 0.02% 763
2015
Q3 		– Sell
-31,733
Closed -$724K – 1092
2015
Q2 		$724K Buy
+31,733
New +$632K 0.04% 495
2015
Q1 		– Sell
-17,766
Closed -$214K – 1097
2014
Q4 		$214K Hold
17,766
– – 0.01% 855
2014
Q3 		$201K Hold
17,766
– – 0.01% 881
2014
Q2 		$215K Buy
+17,766
New +$210K 0.01% 853

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deere & Company's MNTA Position: Q4 2016 in Review

Deere & Company sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2016, closing a stake of 36,181 shares — an estimated $423K sold.

Deere & Company first reported a position in MNTA in Q2 2014 and held it in 6 quarters. The position peaked at $724K in Q2 2015. 160 funds tracked by Wall St. Rank hold MNTA as of Q4 2016.

  • Deere & Company reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 36,181 Momenta Pharmaceuticals, Inc. shares in Q4 2016, an estimated $423K.
  • Deere & Company first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 6 quarters.
  • Deere & Company's Momenta Pharmaceuticals, Inc. position peaked at $724K in Q2 2015.
  • 160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.